Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid, Rebecca Dent
Topics & Concepts
Triple-negative breast cancerPembrolizumabBreast cancerMedicineOncologyInternal medicineCancerImmunotherapyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesCancer Cells and Metastasis